CI in the 13F filings
The Cigna Group · CUSIP 125523100
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 29 Oct 2025
- Managers listing it
- 28
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 26 listed it in both
- Shares listed
- 56,334,585
- combined, among listed positions
- Reported value
- $16.2bn
- combined, at the quarter end
Among the 95 comparable managers: 14 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing CI in Q3 2025
28 of 28 holders
Largest increases and reductions, by shares
Increases
- Capital Research Global Investorsexisting position · 3,179,301 shares now+1,855,897
- T. Rowe Price Associates Incexisting position · 11,302,366 shares now+1,008,534
- Dodge & Coxexisting position · 9,305,225 shares now+354,615
- Invesco Ltdexisting position · 1,900,502 shares now+279,564
- Arrowstreet Capital LPexisting position · 2,695,620 shares now+186,880
Reductions
- MFS Investment Managementexisting position · 10,901,749 shares now-876,723
- D. E. Shaw & Co.existing position · 393,939 shares now-567,391
- Fidelity (FMR LLC)existing position · 10,670,155 shares now-495,635
- AQR Capital Management LLCexisting position · 816,742 shares now-319,652
- Glenview Capital Management LLCexisting position · 187,757 shares now-184,136
New positions and exits
New (1)
Exited (2)
- Artisan Partners LPwas $133m
- Woodline Partners LPwas $59m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2018 | 33 | $20.6bn | n.a. | n.a. |
| Q1 2019 | 27 | $18.1bn | n.a. | n.a. |
| Q2 2019 | 26 | $17.5bn | n.a. | n.a. |
| Q3 2019 | 27 | $16.6bn | n.a. | n.a. |
| Q4 2019 | 28 | $23.1bn | n.a. | n.a. |
| Q1 2020 | 26 | $19.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $20.8bn | n.a. | n.a. |
| Q3 2020 | 34 | $18.1bn | n.a. | n.a. |
| Q4 2020 | 22 | $21.9bn | n.a. | n.a. |
| Q1 2021 | 24 | $23.9bn | n.a. | n.a. |
| Q2 2021 | 31 | $22.5bn | n.a. | n.a. |
| Q3 2021 | 30 | $17.8bn | n.a. | n.a. |
| Q4 2021 | 26 | $20.1bn | n.a. | n.a. |
| Q1 2022 | 28 | $20.4bn | n.a. | n.a. |
| Q2 2022 | 32 | $22.1bn | n.a. | n.a. |
| Q3 2022 | 31 | $21.5bn | n.a. | n.a. |
| Q4 2022 | 30 | $24.7bn | n.a. | n.a. |
| Q1 2023 | 35 | $18.2bn | n.a. | n.a. |
| Q2 2023 | 30 | $19.8bn | n.a. | n.a. |
| Q3 2023 | 28 | $19.8bn | n.a. | n.a. |
| Q4 2023 | 31 | $20.6bn | 16 | 19 |
| Q1 2024 | 28 | $24.0bn | 14 | 17 |
| Q2 2024 | 28 | $19.5bn | 15 | 15 |
| Q3 2024 | 25 | $20.2bn | 13 | 14 |
| Q4 2024 | 23 | $15.2bn | 13 | 12 |
| Q1 2025 | 24 | $18.4bn | 15 | 10 |
| Q2 2025 | 34 | $19.5bn | 24 | 10 |
| Q3 2025 | 28 | $16.2bn | 14 | 15 |
| Q4 2025 | 21 | $14.6bn | 20 | 23 |
| Q1 2026 | 26 | $13.5bn | 19 | 20 |
| Q2 2026 | 28 | $13.0bn | 22 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CI and UNH →CI and ELV →CI and HUM →Choose a stock to compare with CI →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CI, latest filings →Back to the 13F Explorer →